Integration of single-cell RNA and bulk RNA sequencing revealed malignant ductal cell heterogeneity and prognosis signatures in pancreatic cancer

IntroductionPancreatic cancer is a highly malignant tumor of the digestive system with a dismal prognosis. Despite advances in diagnosis and treatment, overall survival remains extremely low. Early diagnostic markers and an improved understanding of tumor-microenvironment interactions are essential...

Full description

Saved in:
Bibliographic Details
Main Authors: Haiyang Du, Gao Si, Jiqing Si, Xuejie Song, Fuchun Si
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-07-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1579184/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849429227460362240
author Haiyang Du
Haiyang Du
Gao Si
Jiqing Si
Xuejie Song
Xuejie Song
Fuchun Si
Fuchun Si
author_facet Haiyang Du
Haiyang Du
Gao Si
Jiqing Si
Xuejie Song
Xuejie Song
Fuchun Si
Fuchun Si
author_sort Haiyang Du
collection DOAJ
description IntroductionPancreatic cancer is a highly malignant tumor of the digestive system with a dismal prognosis. Despite advances in diagnosis and treatment, overall survival remains extremely low. Early diagnostic markers and an improved understanding of tumor-microenvironment interactions are essential for developing more effective therapies.MethodsWe analyzed 74 single-cell RNA sequencing (scRNA-seq) samples, performing unsupervised clustering and marker-gene expression profiling to define major cell types. Large-scale chromosomal copy-number variation (CNV) analysis distinguished malignant from non-malignant ductal cells. Non-negative matrix factorization (NMF) identified stage-associated gene modules, which were integrated with TCGA bulk-RNA data and machine-learning feature selection to pinpoint candidate prognostic genes. Two independent cohorts were used for validation. Regulatory network inference (pySCENIC) and ligand–receptor interaction analysis (CellPhoneDB) explored cross-talk between malignant cells and macrophages. Finally, in vitro knockdown of CTSV assessed its functional role in pancreatic cancer (PAC) cell proliferation and migration.ResultsThree prognosis-related genes—ANLN, NT5E, and CTSV—were selected based on their strong association with clinical stage and validated in external datasets. High expression of these genes correlated with poorer overall survival and an increased infiltration of M0 macrophages. CellPhoneDB predicted significant interactions between high-expression malignant ductal cells and M0 macrophages via CXCL14–CXCR4 and IL1RAP–PTPRF axes, with SPI1 identified as an upstream regulator of IL1RAP. In vitro CTSV knockdown significantly inhibited PAC cell proliferation and migration.DiscussionOur integrative single-cell and bulk-RNA workflow identifies ANLN, NT5E, and CTSV as novel prognostic biomarkers in pancreatic cancer and highlights a pro-tumorigenic interaction between malignant ductal cells and macrophages. Targeting CTSV or disrupting CXCL14–CXCR4 and IL1RAP–PTPRF signaling may offer new therapeutic avenues for PAC.
format Article
id doaj-art-aa1bbfefb3b1456ca87f8a60342303e3
institution Kabale University
issn 1664-3224
language English
publishDate 2025-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj-art-aa1bbfefb3b1456ca87f8a60342303e32025-08-20T03:28:25ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-07-011610.3389/fimmu.2025.15791841579184Integration of single-cell RNA and bulk RNA sequencing revealed malignant ductal cell heterogeneity and prognosis signatures in pancreatic cancerHaiyang Du0Haiyang Du1Gao Si2Jiqing Si3Xuejie Song4Xuejie Song5Fuchun Si6Fuchun Si7Henan University of Chinese Medicine, Traditional Chinese Medicine (Zhongjing) School, Zhengzhou, ChinaHenan University of Chinese Medicine, Henan Key Laboratory of Traditional Chinese Medicine (TCM) Syndrome and Prescription Signaling, Henan International Joint Laboratory of Traditional Chinese Medicine (TCM) Syndrome and Prescription Signaling, Academy of Chinese Medical Sciences, Zhengzhou, ChinaDepartment of Orthopedic, The Third Hospital of Peking University, Beijing, ChinaHenan Hospital of Traditional Chinese Medicine (TCM), The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, ChinaHenan University of Chinese Medicine, Traditional Chinese Medicine (Zhongjing) School, Zhengzhou, ChinaHenan University of Chinese Medicine, Henan Key Laboratory of Traditional Chinese Medicine (TCM) Syndrome and Prescription Signaling, Henan International Joint Laboratory of Traditional Chinese Medicine (TCM) Syndrome and Prescription Signaling, Academy of Chinese Medical Sciences, Zhengzhou, ChinaHenan University of Chinese Medicine, Traditional Chinese Medicine (Zhongjing) School, Zhengzhou, ChinaHenan University of Chinese Medicine, Henan Key Laboratory of Traditional Chinese Medicine (TCM) Syndrome and Prescription Signaling, Henan International Joint Laboratory of Traditional Chinese Medicine (TCM) Syndrome and Prescription Signaling, Academy of Chinese Medical Sciences, Zhengzhou, ChinaIntroductionPancreatic cancer is a highly malignant tumor of the digestive system with a dismal prognosis. Despite advances in diagnosis and treatment, overall survival remains extremely low. Early diagnostic markers and an improved understanding of tumor-microenvironment interactions are essential for developing more effective therapies.MethodsWe analyzed 74 single-cell RNA sequencing (scRNA-seq) samples, performing unsupervised clustering and marker-gene expression profiling to define major cell types. Large-scale chromosomal copy-number variation (CNV) analysis distinguished malignant from non-malignant ductal cells. Non-negative matrix factorization (NMF) identified stage-associated gene modules, which were integrated with TCGA bulk-RNA data and machine-learning feature selection to pinpoint candidate prognostic genes. Two independent cohorts were used for validation. Regulatory network inference (pySCENIC) and ligand–receptor interaction analysis (CellPhoneDB) explored cross-talk between malignant cells and macrophages. Finally, in vitro knockdown of CTSV assessed its functional role in pancreatic cancer (PAC) cell proliferation and migration.ResultsThree prognosis-related genes—ANLN, NT5E, and CTSV—were selected based on their strong association with clinical stage and validated in external datasets. High expression of these genes correlated with poorer overall survival and an increased infiltration of M0 macrophages. CellPhoneDB predicted significant interactions between high-expression malignant ductal cells and M0 macrophages via CXCL14–CXCR4 and IL1RAP–PTPRF axes, with SPI1 identified as an upstream regulator of IL1RAP. In vitro CTSV knockdown significantly inhibited PAC cell proliferation and migration.DiscussionOur integrative single-cell and bulk-RNA workflow identifies ANLN, NT5E, and CTSV as novel prognostic biomarkers in pancreatic cancer and highlights a pro-tumorigenic interaction between malignant ductal cells and macrophages. Targeting CTSV or disrupting CXCL14–CXCR4 and IL1RAP–PTPRF signaling may offer new therapeutic avenues for PAC.https://www.frontiersin.org/articles/10.3389/fimmu.2025.1579184/fullpancreatic cancertumor microenvironmentCTSVmacrophagesCXCL14-CXCR4
spellingShingle Haiyang Du
Haiyang Du
Gao Si
Jiqing Si
Xuejie Song
Xuejie Song
Fuchun Si
Fuchun Si
Integration of single-cell RNA and bulk RNA sequencing revealed malignant ductal cell heterogeneity and prognosis signatures in pancreatic cancer
Frontiers in Immunology
pancreatic cancer
tumor microenvironment
CTSV
macrophages
CXCL14-CXCR4
title Integration of single-cell RNA and bulk RNA sequencing revealed malignant ductal cell heterogeneity and prognosis signatures in pancreatic cancer
title_full Integration of single-cell RNA and bulk RNA sequencing revealed malignant ductal cell heterogeneity and prognosis signatures in pancreatic cancer
title_fullStr Integration of single-cell RNA and bulk RNA sequencing revealed malignant ductal cell heterogeneity and prognosis signatures in pancreatic cancer
title_full_unstemmed Integration of single-cell RNA and bulk RNA sequencing revealed malignant ductal cell heterogeneity and prognosis signatures in pancreatic cancer
title_short Integration of single-cell RNA and bulk RNA sequencing revealed malignant ductal cell heterogeneity and prognosis signatures in pancreatic cancer
title_sort integration of single cell rna and bulk rna sequencing revealed malignant ductal cell heterogeneity and prognosis signatures in pancreatic cancer
topic pancreatic cancer
tumor microenvironment
CTSV
macrophages
CXCL14-CXCR4
url https://www.frontiersin.org/articles/10.3389/fimmu.2025.1579184/full
work_keys_str_mv AT haiyangdu integrationofsinglecellrnaandbulkrnasequencingrevealedmalignantductalcellheterogeneityandprognosissignaturesinpancreaticcancer
AT haiyangdu integrationofsinglecellrnaandbulkrnasequencingrevealedmalignantductalcellheterogeneityandprognosissignaturesinpancreaticcancer
AT gaosi integrationofsinglecellrnaandbulkrnasequencingrevealedmalignantductalcellheterogeneityandprognosissignaturesinpancreaticcancer
AT jiqingsi integrationofsinglecellrnaandbulkrnasequencingrevealedmalignantductalcellheterogeneityandprognosissignaturesinpancreaticcancer
AT xuejiesong integrationofsinglecellrnaandbulkrnasequencingrevealedmalignantductalcellheterogeneityandprognosissignaturesinpancreaticcancer
AT xuejiesong integrationofsinglecellrnaandbulkrnasequencingrevealedmalignantductalcellheterogeneityandprognosissignaturesinpancreaticcancer
AT fuchunsi integrationofsinglecellrnaandbulkrnasequencingrevealedmalignantductalcellheterogeneityandprognosissignaturesinpancreaticcancer
AT fuchunsi integrationofsinglecellrnaandbulkrnasequencingrevealedmalignantductalcellheterogeneityandprognosissignaturesinpancreaticcancer